Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Change in Account Payables (2016 - 2021)

Phio Pharmaceuticals' Change in Account Payables history spans 10 years, with the latest figure at -$39000.0 for Q4 2021.

  • For Q4 2021, Change in Account Payables fell 178.57% year-over-year to -$39000.0; the TTM value through Dec 2021 reached -$445000.0, down 449.38%, while the annual FY2025 figure was $183000.0, 145.3% up from the prior year.
  • Change in Account Payables reached -$39000.0 in Q4 2021 per PHIO's latest filing, down from -$26000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $261000.0 in Q3 2020 to a low of -$447000.0 in Q1 2017.
  • Average Change in Account Payables over 5 years is -$41800.0, with a median of -$32500.0 recorded in 2017.
  • Peak YoY movement for Change in Account Payables: soared 1610.0% in 2019, then crashed 1460.0% in 2020.
  • A 5-year view of Change in Account Payables shows it stood at -$191000.0 in 2017, then surged by 130.89% to $59000.0 in 2018, then tumbled by 179.66% to -$47000.0 in 2019, then soared by 70.21% to -$14000.0 in 2020, then tumbled by 178.57% to -$39000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Change in Account Payables are -$39000.0 (Q4 2021), -$26000.0 (Q3 2021), and -$267000.0 (Q2 2021).